AHR and hepatocellular carcinoma: Knockaert et al.49 described that some indirubin derivatives (I3M and BIO) in mouse hepatomas are more kinase active—leading to stronger cytotoxic effects—while other compounds more strongly activate AhR-dependent signals (MelO, MeBIO), leading to cytostatic effects by inducing G1 cell cycle arrest.